Medical castration of males with megestrol acetate and small doses of diethylstilbestrol

The Journal of Clinical Endocrinology and Metabolism
J GellerD Loza

Abstract

An alternative program for medical castration for treatment of prostate cancer has been developed using a progestational antiandrogen, megestrol acetate (MA), in combination with small doses of diethylstilbestrol (DES; 0.1 mg/day). The administration of MA (40-80 mg/day) with 0.1 mg DES to nine patients resulted in castrate levels of plasma testosterone (less than 0.4 ng/ml) and significant suppression of both FSH and LH (P less than 0.05) for up to 12 months. Although large clinical trials must ultimately establish its safety, clinical side effects of this combined therapy to date have consisted of mild gynecomastia in two patients. The symptoms did not necessitate discontinuing the medications. It is concluded that the use of 0.1 mg DES with a minimum of 40 mg/day MA results in medical castration with sustained suppression of plasma testosterone. Because of the possible additional therapeutic advantage of blockade of intracellular androgen-mediated action by MA in androgen-dependent tumors, this combined therapy should be further explored as a possible initial treatment of choice for advanced prostate cancer.

Citations

Mar 1, 1984·Journal of Steroid Biochemistry·S L SchneiderA A Sandberg
Nov 1, 1986·Journal of Steroid Biochemistry·F Di Silverio, F Sciarra
Oct 1, 1988·Journal of Steroid Biochemistry·M Moguilewsky, M M Bouton
Jan 1, 1984·Pharmacology & Therapeutics·D J TindallG R Cunningham
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·P Vacher
Oct 8, 1998·The New England Journal of Medicine·M A EisenbergerB A Lowe
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C ChangC C Shih
Jun 22, 1999·AIDS Patient Care and STDs·D J Farrar
Nov 1, 1991·Journal of Endocrinological Investigation·J Geller
Jan 20, 2007·Journal of the American Geriatrics Society·Dennis H SullivanMelinda M Bopp
Mar 1, 1989·Cancer Treatment Reviews·L SchacterL Smaldone
Jun 1, 1983·Clinical Endocrinology·J Sandow
Dec 1, 1995·The Journal of Urology·R L Cox, E D Crawford
Jun 1, 1996·Hematology/oncology Clinics of North America·M Robson, N Dawson
Feb 1, 1993·Cancer·F Daneshgari, E D Crawford
Feb 1, 1993·Cancer·D G McLeod
May 15, 1985·Cancer·R M WolfA A Sandberg
Oct 1, 1986·The Journal of Urology·S Burton, J Trachtenberg
May 1, 1984·The Journal of Pharmacy and Pharmacology·V PetrowS A Marts
Jan 1, 1989·Journal of Surgical Oncology. Supplement·A D SeftelM I Resnick
Nov 2, 2019·The Journal of Steroid Biochemistry and Molecular Biology·Monique BarnardKarl-Heinz Storbeck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.